Health Coaching for Glaucoma Patients

Glaucoma Clinical Trial

Official title:

Health Coaching for Glaucoma Patients, Pilot Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02090777
• Other study ID #: Pro00052498
• Status: Completed
• Phase: N/A
• First received: March 14, 2014
• Last updated: February 17, 2016
• Start date: May 2014
• Est. completion date: April 2015

Study information

• Verified date: January 2016
• Source: Duke University
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Interventional

Clinical Trial Summary

The study will be conducted to examine the feasibility of using a Health Coach for improving the ophthalmic care of glaucoma patients. Patients taking glaucoma medications will have a coaching intervention and adherence to glaucoma drops will be monitored using a dose-recording device. The dosing data will be analyzed to examine the effect on adherence and qualitative interviews at the conclusion of the study will be used to examine which elements of the coaching experience were most helpful in the glaucoma patient population.

Description:

Glaucoma medication adherence will be tracked using a dose recording device to record eye drop usage.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 9
• Est. completion date: April 2015
• Est. primary completion date: April 2015
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Adult whose age is >18 years

• Diagnosed with glaucoma

• Patient of Duke Glaucoma Service

• Prescribed or using topical glaucoma eye medication for at least 6 months

• Primarily self-administering his or her eye drops

• English speaking

• Patient should be able to use the telephone for the coaching intervention,

• Patient should be available by phone to complete the coaching intervention

• Patient should be willing and able to use the MEMS (Medication Event Monitoring System) device for recording medication use

• Patient must be willing and able to come to the Eye Center for an exit interview and to return the MEMS device

• Patient must be able to give consent

Exclusion Criteria:

• Patient should be excluded if he or she may need glaucoma surgery or laser during the 6 months of the study period

Study Design

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Health Services Research

Related Conditions & MeSH terms

• Glaucoma

Intervention

Behavioral:
• Health Coach

Locations

Country	Name	City	State
United States	Duke Eye Center	Durham	North Carolina

Sponsors (1)

Lead Sponsor	Collaborator
Duke University

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Glaucoma Medication Adherence	Glaucoma medication adherence will be tracked using a dose recording device to record eye drop usage. The average of the participants percentage of time they adhered to using the medication will be reported.	6 Months	No